MELEA MCCORMICK: Open Payments
NPI 1225722804 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,173 in 57 payments from 18 companies in 2025. Trend: 2023 $153 · 2024 $852 · 2025 $1,173
Food & beverage: $1,173
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $416 |
| ABBVIE INC. | 9 | $179 |
| Amgen Inc. | 6 | $99 |
| Novo Nordisk Inc | 4 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $66 |
| GlaxoSmithKline, LLC. | 4 | $56 |
| PFIZER INC. | 3 | $43 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Exact Sciences Corporation | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
Products named: BREZTRI, AIRSUPRA, VRAYLAR, Kerendia, OTEZLA, UBRELVY, PREVNAR 20, GEMTESA.
Industry payments across AR — which companies pay providers there.
